At a Glance
Asabys Partners is a venture capital firm based in Barcelona, Spain founded in 2017. The firm focuses on Pre-Seed, Seed, Series A, Series B+ investments across sectors including Aerospace & Defense, Digital Health, Other, Consumer, Fintech. The firm manages €100M in assets under management. Notable portfolio companies include Oryzon Genomics, Ability Pharma, Gate2Brain and Minoryx Therapeutics. Focuses on early-stage life sciences and digital health companies in Europe, particularly therapeutics, medical devices, and healthtech platforms.
“Focuses on early-stage life sciences and digital health companies in Europe, particularly therapeutics, medical devices, and healthtech platforms.”
Asabys Partners primarily invests at the Pre-Seed, Seed, Series A, Series B+ stages. This means they focus on companies that are at the earliest idea or prototype phase.
Asabys Partners is headquartered in Barcelona, Spain. Many of their portfolio companies are also based in this region, though they invest across geographies.
Asabys Partners focuses on investments in Aerospace & Defense, Digital Health, Other, Consumer, Fintech. Their portfolio reflects deep expertise and networks within these sectors.
Asabys Partners's typical investment check size ranges from $. to $.. Actual amounts may vary based on the stage, sector, and specific opportunity.
Asabys Partners manages approximately €100M in assets under management (AUM) across their funds.
